Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 21, 2025 04:01 ET | Source: Research and Markets

Retinitis Pigmentosa Treatment Market Forecast Report 2024-2032: Retinitis Pigmentosa Treatment Market Set to Double by 2032, Driven by Gene Therapy Advances

Dublin, April 21, 2025 (GLOBE NEWSWIRE) -- The "Retinitis Pigmentosa Treatment Market Report and Forecast 2024-2032" has been added to ResearchAndMarkets.com's offering.The retinitis pigmentosa...
April 08, 2025 06:08 ET | Source: Research and Markets

Age-related Macular Degeneration Market Report 2025-2030 - Asia-Pacific and EMEA Fuel Growth in AMD Market with Reforms and Expanding Access to Vision Care

Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Age-related Macular Degeneration Market by Type (Dry Age-Related Macular Degeneration, Wet Age-Related Macular Degeneration), Treatment Modality...
August 08, 2023 07:28 ET | Source: Research and Markets

The US Vision Care Market: Rising Demand for Eye Care Products Drives Growth, Forecast to Reach $33.4 Billion by 2028

Dublin, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The "US Vision Care Market: Analysis, Trends and Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The report offers a...
June 08, 2023 11:03 ET | Source: Research and Markets

NR2E3 Mutation-Associated Retinal Degeneration Market Insights, Epidemiology and Forecasts, 2032 - Focus on United States, Germany, Spain, Italy, France, United Kingdom and Japan

Dublin, June 08, 2023 (GLOBE NEWSWIRE) -- The "NR2E3 Mutation - Associated Retinal Degeneration - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ...
January 20, 2023 01:23 ET | Source: Douglas Insights

Leber Congenital Amaurosis Market Is Estimated to Grow at CAGR Of 4.8%, 2022-2029 | Latest Industry Coverage by Douglas Insights

Douglas, Jan. 20, 2023 (GLOBE NEWSWIRE) -- The Leber Congenital Amaurosis Market Report by Douglas Insights aims to inform about the details of growing developments, market share, and any localized...
February 04, 2021 11:17 ET | Source: Connectyx Technologies Holdings Group, Inc

Connectyx Announces Grant of Exclusive Worldwide License from National Institutes of Health for Repurposing Metformin to Treat Degenerative Eye Disease

Boca Raton, FL, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel...
November 27, 2019 07:00 ET | Source: Foundation Fighting Blindness

Foundation Fighting Blindness Launches Natural History Study for People with Retinitis Pigmentosa Caused by EYS Gene Mutations

Columbia, MD, Nov. 27, 2019 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness has launched a natural history study (NCT04127006) for people with retinitis pigmentosa (RP) caused by mutations in...